This product has been shown in clinical studies to be 2X more effective than glucosamine & chondroitin.
Salt Lake City, UT (PRWEB) June 26, 2013
TFX Health, LLC has teamed up with GNC to launch a new joint health supplement that is expected to revolutionize the joint health industry. In addition to 12 different vitamins and nutrients, TFX Flex™ contains a breakthrough new dietary ingredient known as UC-II® that has been proven in human clinical studies to be 2X more effective than Glucosamine & Chondroitin for joint pain relief.
UC-II® was developed by a team of scientists with more than 25 years of experience in the development of patented, clinically proven dietary ingredients. It holds 7 international and U.S. patents and is supported by 9 human clinical studies, including research at Harvard Medical School.
In a randomized, double-blind, placebo-controlled human clinical study it was found that only 40 mg of UC-II® Undenatured Type II Collagen was more than two times as effective as 1,500 mg of glucosamine and 1,200 mg of chondroitin in supporting joint health, comfort and flexibility. It outperformed the glucosamine & chondroitin combination in three different joint pain relief assessment tools: WOMAC, VAS and the Lequesne Functional Index. UC-II® significantly decreased joint pain during daily activities, including walking on a flat surface, performing heavy domestic duties, ascending stairs and while resting in bed. UC-II® was also shown to be safe and well tolerated with no known side effects [Crowley DC, Lau FC, Sharma P, et al. Int J Med Sci. 2009; 6:312-321].
This is considered ground-breaking news that is expected to revolutionize the joint health supplement industry that currently exceeds more than $2 Billion in annual worldwide sales of glucosamine & chondroitin. Researchers have been frantically looking for better alternatives since glucosamine & chondroitin came under fire after a 2010 study published in the British Medical Journal. The study concluded that, “Glucosamine and Chondroitin, either taken together or separately, have not shown a clinically significant improvement in joint pain relief for patients troubled with knee or hip osteoarthritis [BMJ 2010; 341:c4675]. The author of the study stated that, “Our findings indicate that glucosamine, chondroitin, and their combination do not result in a relevant improvement in joint pain relief nor affect joint space narrowing compared with placebo.”
A TFX Health company spokesman explained, “The science behind joint health is rapidly changing and TFX Flex™ is uniquely positioned to replace the $2 billion market for the same tired old joint pain remedies. This product has been shown in human clinical studies to be 2X more effective than glucosamine & chondroitin. Not only that, TFX Flex™ is the only product on the market that combines clinically proven ingredients for muscle, bone, and joint support providing a safe and effective solution for the entire musculoskeletal system.”
To learn more about TFX Flex™Joint Health Supplement please visit http://www.TFXflex.com/ or go directly to GNC.com at http://www.gnc.com/product/index.jsp?productId=13339949&kwCatId=
About TFX Health, LLC
Based in Salt Lake City, the heart of the dietary supplement industry, TFX Health, LLC is an innovative pioneer in the development of cutting edge health and wellness products. The company’s brands include TFX Flex™ Joint Health Supplement, TFX Drive™ Testosterone Booster, TFX Elite™ Extreme Thermogenic, NO5X™ Nitric Oxide Booster, and other high end formulations as well as a full line of weight loss supplements including Garcinia, Saffron, and Black Bean Extract. All TFX Health products are proudly manufactured in the USA and distributed worldwide through online and traditional retail channels. All TFX Health products are manufactured in FDA registered, cGMP compliant facilities following the highest standards of quality control procedures. For more information, please visit http://www.TFXflex.com/
UC-II® is a registered trademark of InterHealth N.I. Clinical data is on file and available upon request. U.S. Patents 5,645,851; 5,637,321; 5,529,786; 5,750,144; 7,083,820; 7,846,487, EPO Patent 1435906B1 and worldwide patents pending.